Search Results 451-460 of 12897 for immunosuppressant drugs

  1. Project 4: P95HER2, Antitumor Immunity and the Efficacy of HER2-Directed Antibody Drug Conjugates - Mayo Clinic Research

    Drugs & Supplements · Healthy Lifestyle · Mayo Clinic ... immunosuppressive tumor microenvironment in breast cancer. ... Your donation powers the future of medicine ...

  2. Cowboy Back in Saddle After Successful Treatment of Glomerulonephritis - Mayo Clinic News Network

    In June 2013, Jack began receiving an immunosuppressant drug intravenously a part of a Mayo Clinic research study. He participated in the study for six ...

  3. Mometasone and formoterol (inhalation route) - Side effects & dosage - Mayo Clinic

    This medicine will not relieve an asthma attack that has already started. Mometasone belongs to the family of medicines known as corticosteroids (cortisone-like ...

  4. Clofazimine (oral route) - Side effects & dosage - Mayo Clinic

    Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for ...

  5. Umbralisib (oral route) - Side effects & dosage - Mayo Clinic

    Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the ...

  6. Emtricitabine and tenofovir alafenamide (oral route) - Side effects & dosage - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  7. Rheumatoid Arthritis Patients in Sustained Remission Biorepository - Mayo Clinic

    Identifying biomarkers associated with failure vs success of immunosuppressive treatments (DMARD) tapering is a critical need which will allow to maximize the ...

  8. Oncology (Medical) - Clinical trials

    Mayo Clinic College of Medicine and Science ... A Study to Test the Effectiveness of Two Immunotherapy Drugs ... immunosuppressants. Exploratory Goals. To evaluate ...

  9. Guidance on patients at risk of drug-induced sudden cardiac death from off-label COVID-19 treatments - Mayo Clinic News Network

    ... immunosuppression or having another high-risk condition, the potential benefit of QTc-prolonging medicines may exceed the arrhythmia risk. "Importantly, the ...

  10. Immune globulin-stwk (intravenous route) - Side effects & uses - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...